Dr. Ahmed AK Hassoun
Designation: Clinical Professor & Senior Consultant Endocrinologist
Specialty: Endocrinology, Diabetes, and Metabolism
Languages: English and Arabic
- Diabetology – all types of diabetes (2, 1, gestational & others)
- Obesity, metabolic syndrome, pre-diabetes
- Thyroid diseases and tumors (including pregnancy related)
- Bone and Mineral disorders (including osteoporosis, parathyroid gland, and calcium)
- Hypertensive disorder (secondary and resistant)
- Adrenal gland diseases and tumors
- Pituitary gland disease and tumors
- Male hormone disorders (including erectile dysfunction, gynecomastia, and hypogonadism)
- Female hormone disorders (including polycystic ovarian syndrome, and hypogonadism)
Dr. Hassoun completed his residency and fellowship in Internal Medicine & Endocrinology at Brown University & the Mayo Clinic, respectively. After 3 years of extensive clinical and research fellowship he joined the Endocrinology staff at Mayo Clinic in Rochester, MN, USA.
Dr. Hassoun is a fellow of the American College of Physicians and the American College of Endocrinology. In addition, he is an active member of American Diabetes Association (ADA), the Endocrine Society (ES), and the American Association of Clinical Endocrinologists (AACE).
His previous appointments included Chief of Endocrinology, Clinical Assistant Professor at Wayne State University in Michigan and the Faculty of Medicine, UAE University. Until recently, and for more than 12 years, he worked as a Senior Consultant Endocrinologist, and Chairman of Research & Medical Education at the Dubai Diabetes Center.
He has been actively participating in developing and updating the UAE Diabetes guidelines, educating and training doctors and other healthcare providers, as well as conducting research in the field of diabetes and endocrinology.
Dr. Hassoun is a co-founder of the monthly UAE Endocrinology meetings (Endocrine club), which was established in the year 2002. In addition, he was the Founding and the 1st President of the AACE Gulf Chapter, which was established in 2012.
Dr. Hassoun received several awards including the 2019 ‘Ibn Sina Distinguished Service Award’ the American Association of Clinical Endocrinologists – Gulf Chapter. He has authored and co-authored more than 50 articles and abstracts in the field of diabetes and in the other areas of endocrinology.
- Clinical Professor, Dubai Medical University
- American Board Certified in Endocrinology, Diabetes and Metabolism, USA
- American Board Certified in Internal Medicine, USA
- 1st President – American Association of Clinical Endocrinologist Gulf Chapter
- Staff Endocrinologist, Clinical and Research Fellow in Endocrinology, Mayo Clinic, Rochester, USA
- Fellow – American College of Physicians & American College of Endocrinology
- Member of American Association of Clinical Endocrinologist
- Member of American Diabetes Association
- Member of Endocrinology Society
- Member of the Emirates Medical Association, UAE
- MD, 1973-1979, Aleppo University Faculty of Medicine, Aleppo, Syria
Research & Publications
- Factors predicting the development of diabetic retinopathy in patients with diabetes at the Dubai Diabetes Center) (ongoing)
- Effect and safety of Semaglutide 2.4 mg once weekly in subjects with overweight or obesity and type 2 diabetes (Step 2) (ongoing)
- Depression, diabetes distress and quality of life among diabetic patients attending Dubai Diabetes Center
- Diabetes distress and depression and its effect on glycemic control in a sample of adolescent patients with type 1 diabetes attending a diabetes center in Dubai, United Arab Emirates
- Real world assessment of clinical outcome changes – including month of Ramadan – for dapagliflozin in management of type 2 diabetes mellitus (reward study)
A few of his many publications and abstracts include:
- The effect of frequent diabetes self-management education on glucose control in patients with diabetes at the Dubai Diabetes Center – Journal of diabetes and endocrine practice. Volume 2; Issue 1, January-March 2019
- Interaction between angiotensin converting enzyme (ace) insertion/deletion and aldosterone synthase (cyp11b2) – 344c/t polymorphisms in relation to type 2 diabetes mellitus risk in Emiratis. International Journal of Genetics and Molecular Biology; 2013; 5(2), pp. 20-27
- Prevalence of painful diabetic peripheral neuropathy among patients with diabetes mellitus in the middle east region. The Journal of International Medical Research. 2011: 39 (2): 366-377
- Hepatitis C associated osteosclerosis: an unusual syndrome of acquired osteosclerosis in adults. Am J Med. 1997 Jul. 103 (1): 70-3
- Glycated hemoglobin in insulinoma. Endocrine practice. 1998 July/August; 4(4): 181-183
- Tolerability of canagliflozin in patients with type 2 diabetes mellitus fasting during Ramadan: results of the canagliflozin in Ramadan tolerance observational study (cratos). Int j clin pract. 2017 oct;71(10). Doi: 10.1111/ijcp.12991. Epub 2017 aug 29.
- Elevated hemoglobin a1c is significantly associated with decreased post-exercise heart rate recovery in parents with diabetes mellitus. Intj diabetes clin res 2017, 4:074.
- Self-efficacy, self-care and glycemic control in Saudi Arabian patients with type 2 diabetes mellitus. Diabetes res Clin pract. 2017 Dec 24;137:28-36.
- Goal study: clinical and non-clinical predictive factors for achieving glycemic control in people with type 2 diabetes in real clinical practice. BMJ open diabetes res care. 2018 Jul 10;6(1)
- The diabetes epidemic: investigating the association between t2dm and tcf7l2 gene variants in the emirati population. Accepted for publication in American journal of human biology.
- Genetics of type 2 diabetes and coronary artery disease and their associations with twelve cardiometabolic traits in the United Arab Emirates population. Accepted for publication in “gene”
- Emirates diabetes society consensus guidelines for the management of type 2 diabetes mellitus-2020. Accepted at Dubai diabetes and endocrinology journal
- The effect of frequent diabetes self-management education on glucose control in patients with diabetes at the Dubai diabetes center in Dubai, United Arab Emirates. Journal of diabetes and endocrine practice. Volume 2; issue 1, January-March 2019
- The effect of vildagliptin relative to sulphonylurea as dual therapy with metformin (or as monotherapy) in Muslim patients with type 2 diabetes fasting during Ramadan in the middle east: the virtue study. Curr med res opin. 2017 jan;33(1):161-167. Epub 2016 oct 14.
- The effect of vildagliptin relative to sulphonylureas in Muslim patients with type 2 diabetes fasting during Ramadan: the virtue study. Int j clin pract. 2013 october; 67(10): 957-63.
- Driving and diabetes mellitus in the gulf cooperation council countries: call for action. Diabetes research and clinical practice. 2015 october;110, (1): 91–94
Nationality: American, Iraqi
Number of Years of Experience: 28+ years